Trandolapril

Chemical formula: C₂₄H₃₄N₂O₅  Molecular mass: 430.537 g/mol  PubChem compound: 5484727

Therapeutic indications

Trandolapril is indicated for:

Mild or moderate arterial hypertension

Population group: only adults (18 years old or older)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Left ventricular dysfunction after acute myocardial infarction

Population group: only adults (18 years old or older)

Left ventricular cardiac dysfunction and additionally Acute myocardial infarction

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Trandolapril is contraindicated in the following cases:

Pregnancy

Pregnancy

Idiopathic angioedema

Idiopathic angio-oedema

Hereditary angioedema

Hereditary angioneurotic edema

Aliskiren in diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m²)

Aliskiren and additionally at least one of
Diabetes mellitus



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Sacubitril, valsartan

at least one of
Sacubitril
Valsartan

Angiotensin converting enzyme inhibitor-aggravated angioedema

ACE inhibitor-aggravated angio-oedema

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: TRANDOLAPRIL Capsules
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈